Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1CNS 1

Conditions

Central Nervous System Neoplasms 2Thrombocytopenia 1Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Sarcoma 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasms 1Mouth Neoplasms 1Mesothelioma, Malignant 1Medulloblastoma 1Lymphoma 1Liver Neoplasms 1Laryngeal Neoplasms 1Intraocular Lymphoma 1Hypopharyngeal Neoplasms 1Hyperthermia 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma 1Brain Neoplasms 1Adrenocortical Carcinoma 1Adenocarcinoma 1

Interventions

Radiotherapy 2Pyridoxine 2Etoposide 2Cytarabine 2Cyclophosphamide 2sodium thiosulfate 1pegfilgrastim 1pegaspargase 1etoposide phosphate 1Vincristine 1Triptorelin Pamoate 1Rituximab 1Prednisolone 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Celecoxib 1Carboplatin 1Capecitabine 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Drug-Related Side Effects and Adverse Reactions × sodium thiosulfate × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡